Trial Number

444-23

Condition

Heart Failure

Participant Age Range

40 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

“System II to improve quality of life and reduce heart failure related symptoms and events in patients with heart failure with preserved (HFpEF) or mildly-reduced ejection fraction (HFmrEF) with elevated left atrial pressure, who remain symptomatic despite standard Guideline Directed Medical Therapy”

The purpose of this study is to look at an investigational treatment for heart failure symptoms. This study involves the use of medical device called the Corvia Atrial Shunt System that will be permanently implanted in the heart and is designed to reduce the increased pressure.

Provider

Heart & Vascular Institute

David M Shavelle, MD

Cardiology, Interventional Cardiology
Long Beach
View Profile

Related Clinical Trials

Click on the category you are interested in.

Heart & Vascular Care MemorialCare Medical Group
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.